Please select the option that best describes you:
What is your preferred first-line agent for VTE prophylaxis in hospitalized medical patients with adequate renal function?
Do you prefer heparin, enoxaparin, DOAC, or aspirin?
Do you prefer heparin, enoxaparin, DOAC, or aspirin?